Page 4 - பணக்காரர் ஹெல்ம் உயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பணக்காரர் ஹெல்ம் உயிரியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பணக்காரர் ஹெல்ம் உயிரியல் Today - Breaking & Trending Today

INOVIO to Present at Upcoming Investor Conferences in March

INOVIO to Present at Upcoming Investor Conferences in March
News provided by
Share this article
Share this article
PLYMOUTH MEETING, Pa., March 4, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Dr. J. Joseph Kim, President and CEO, along with other members of INOVIO management, will present at the following investor conferences in March:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Virtual 1x1 meetings only
Date: Thursday, March 18, 2021
Time: 10:40 a.m. ET
Presentation Format: Corporate Presentation ....

Ben Matone , Jeff Richardson , Kaneka Eurogentec , J Joseph Kim , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , National Institute Of Allergy , Plumbline Life Sciences , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , Hc Wainwright Global Life Sciences Conference , International Vaccine Institute , Defense Consortium , Parker Institute For Cancer Immunotherapy , Nuclear Defense , Department Of Defense Do , National Institutes Of Health , Program Executive Office For Chemical , Apollobio Corporation , Vaccines Trial Network , Defense Advanced Research Projects Agency , University Of Pennsylvania , Wistar Institute , Annual Healthcare , Relations Events ,

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results

Share this article
Share this article
PLYMOUTH MEETING, Pa., March 1, 2021 /PRNewswire/ INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today reported financial results for the quarter ended December 31, 2020. INOVIO s management will host a live conference call and webcast at 4:30 p.m. Eastern Standard Time today to discuss financial results and provide a general business update, including: top-line efficacy data from REVEAL 1, a Phase 3 clinical trial of VGX-3100; a progress update for the company s INNOVATE Phase 2/3 COVID-19 vaccine clinical trial and its development strategy regarding the new COVID-19 vaccine addressing the current and future COVID variants of concern (VOC); and a general update on its DNA medicines platform. The live webcast and a replay may be accessed by visiting INOVIO s website at http: ....

United States , Hong Kong , United Kingdom , South Africa , Macau General , South African , Ben Matone , Jeff Richardson , Kaneka Eurogentec , J Joseph Kim , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , National Institute Of Allergy , Us Department Of Defense Do , Plumbline Life Sciences , Melinda Gates Foundation , Inovio Pharmaceuticals Inc , Coalition For Epidemic Preparedness Innovations , Society For Neuro , Defense Consortium , Parker Institute For Cancer Immunotherapy , International Vaccine Institute , Pharmaceuticals Inc , Nuclear Defense , Indiana University ,

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , United Kingdom , South Africa , Macau General , South African , Ben Matone , Jeff Richardson , Kaneka Eurogentec , J Joseph Kim , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , National Institute Of Allergy , Us Department Of Defense Do , Plumbline Life Sciences , Melinda Gates Foundation , Inovio Pharmaceuticals Inc , Coalition For Epidemic Preparedness Innovations , Society For Neuro , Defense Consortium , Parker Institute For Cancer Immunotherapy , International Vaccine Institute , Pharmaceuticals Inc , Nuclear Defense , Indiana University ,

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa
ghanavisions.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghanavisions.com Daily Mail and Mail on Sunday newspapers.

Ben Matone , Jeff Richardson , Kaneka Eurogentec , Kwadwoa Koram , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , Noguchi Memorial Institute For Medical Research , National Institute Of Allergy , Plumbline Life Sciences , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , International Vaccine Institute , Defense Consortium , Parker Institute For Cancer Immunotherapy , Nuclear Defense , Department Of Defense Do , National Institutes Of Health , Program Executive Office For Chemical , Apollobio Corporation , Vaccines Trial Network , Defense Advanced Research Projects Agency , University Of Pennsylvania , Wistar Institute , Clinical Trial , Noguchi Memorial Institute ,

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa

Share this article
Share this article
PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial (LSV-002), ongoing at the Noguchi Memorial Institute for Medical Research in Accra, Ghana, is the first vaccine clinical trial for Lassa fever to be conducted in West Africa, where the infection is endemic. INO-4500 is also the first vaccine candidate for Lassa fever to enter human trials. ....

Greater Accra , Ben Matone , Jeff Richardson , Kaneka Eurogentec , Melanie Saville , J Joseph Kim , Kwadwoa Koram , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , Noguchi Memorial Institute For Medical Research , National Institute Of Allergy , Noguchi Medical Center , Plumbline Life Sciences , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , Defense Consortium , Parker Institute For Cancer Immunotherapy , International Vaccine Institute , Nuclear Defense , Department Of Defense Do , National Institutes Of Health , Program Executive Office For Chemical , Apollobio Corporation , Defense Advanced Research Projects Agency , Vaccines Trial Network ,